We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+10.2%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.08T
AUM Growth
+$79.9B
Cap. Flow
-$8.94B
Cap. Flow %
-0.83%
Top 10 Hldgs %
25.7%
Holding
3,000
New
159
Increased
1,164
Reduced
1,499
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.45B
2
PINS icon
Pinterest
PINS
+$1.89B
3
TMUS icon
T-Mobile US
TMUS
+$1.89B
4
ZM icon
Zoom
ZM
+$1.77B
5
PATH icon
UiPath
PATH
+$1.71B

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$3.66B
2
CAT icon
Caterpillar
CAT
+$1.32B
3
NFLX icon
Netflix
NFLX
+$1.18B
4
MXIM
Maxim Integrated Products
MXIM
+$1.15B
5
MU icon
Micron Technology
MU
+$1.07B

Sector Composition

Rank Sector Weight
1 Technology 24.62%
2 Healthcare 16.07%
3 Consumer Discretionary 15.29%
4 Communication Services 13.46%
5 Financials 12.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOXX
2751
DELISTED
VOXX International Corporation Class A
VOXX
$172K ﹤0.01%
12,286
-1,861
-13% -$30.2K
PAVM icon
2752
PAVmed
PAVM
$32.2M
$171K ﹤0.01%
59
-82
-58% -$194K
BTU icon
2753
Peabody Energy
BTU
$2.98B
$170K ﹤0.01%
21,431
-16,531
-44% -$97.9K
SRT
2754
DELISTED
Startek Inc.
SRT
$170K ﹤0.01%
23,817
-2,592
-10% -$19.1K
PPSI
2755
Pioneer Power Solutions
PPSI
$33.1M
$167K ﹤0.01%
35,800
-10,300
-22% -$42.7K
IMDX
2756
Insight Molecular Diagnostics
IMDX
$138M
$166K ﹤0.01%
1,444
-920
-39% -$89.8K
CASI
2757
DELISTED
CASI Pharmaceuticals
CASI
$163K ﹤0.01%
10,520
-5,009
-32% -$84.3K
MBT
2758
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$163K ﹤0.01%
17,600
NBEV
2759
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$160K ﹤0.01%
71,943
+1,047
+1% +$2.44K
TFFP
2760
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$159K ﹤0.01%
660
ATOS icon
2761
Atossa Therapeutics
ATOS
$24.2M
$157K ﹤0.01%
+1,656
New +$87.7K
HDSN
2762
Hudson Technologies
HDSN
$240M
$157K ﹤0.01%
46,060
-9,100
-16% -$21.9K
NG icon
2763
NovaGold Resources
NG
$3.38B
$157K ﹤0.01%
19,624
+3,568
+22% +$33.6K
LCI
2764
DELISTED
Lannett Company, Inc.
LCI
$157K ﹤0.01%
8,400
+1,812
+28% +$34.8K
FLXN
2765
DELISTED
Flexion Therapeutics, Inc.
FLXN
$157K ﹤0.01%
19,058
+507
+3% +$4.31K
DOYU
2766
DouYu International Holdings
DOYU
$137M
$155K ﹤0.01%
2,270
IZEA icon
2767
IZEA Worldwide
IZEA
$53.4M
$154K ﹤0.01%
15,125
-8,775
-37% -$115K
INOD icon
2768
Innodata
INOD
$1.99B
$153K ﹤0.01%
21,800
-7,900
-27% -$53.5K
LCTX icon
2769
Lineage Cell Therapeutics
LCTX
$273M
$153K ﹤0.01%
53,731
+9,931
+23% +$25.7K
AWH
2770
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$152K ﹤0.01%
1,798
-46
-2% -$3.95K
ATXS
2771
DELISTED
Astria Therapeutics
ATXS
$151K ﹤0.01%
11,967
-238
-2% -$3.09K
GNE icon
2772
Genie Energy
GNE
$385M
$151K ﹤0.01%
23,842
-959
-4% -$5.88K
WYY icon
2773
WidePoint Corp
WYY
$113M
$150K ﹤0.01%
20,700
-19,400
-48% -$153K
IVAC
2774
DELISTED
Intevac Inc
IVAC
$150K ﹤0.01%
22,200
+4,890
+28% +$31.8K
OVID icon
2775
Ovid Therapeutics
OVID
$528M
$148K ﹤0.01%
37,961
+1,213
+3% +$4.79K

Similar funds

T. Rowe Price Associates's Q2 2021 Portfolio in Review

As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
  • T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
  • T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
  • T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
  • T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
  • T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.

Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.